Literature DB >> 8844673

Kinetic analysis of plasmepsins I and II aspartic proteases of the Plasmodium falciparum digestive vacuole.

K E Luker1, S E Francis, I Y Gluzman, D E Goldberg.   

Abstract

Plasmepsins I and II are Plasmodium falciparum aspartic proteases implicated in hemoglobin degradation. Using a synthetic fluorogenic peptide substrate based on the initial hemoglobin cleavage site, we have analyzed kinetic parameters of the two enzymes in native and recombinant forms. Both native plasmepsins cleave the model substrate well. Recombinant plasmepsin II behaves similarly to native enzyme, substantiating its usefulness for inhibition and structural studies. In contrast, recombinant plasmepsin I does not resemble its native homolog kinetically. A hybrid molecule, in which the polyproline loop of plasmepsin I has been replaced by the homologous sequence from plasmepsin II, still maintains the specificity/kinetics of plasmepsin II. This suggests that the polyproline loop, important for substrate recognition in the mammalian aspartic protease renin, does not play a similar role in the plasmepsins.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8844673     DOI: 10.1016/0166-6851(96)02651-5

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  14 in total

1.  Plasmodium food vacuole plasmepsins are activated by falcipains.

Authors:  Mark E Drew; Ritu Banerjee; Eric W Uffman; Scott Gilbertson; Philip J Rosenthal; Daniel E Goldberg
Journal:  J Biol Chem       Date:  2008-02-28       Impact factor: 5.157

Review 2.  Malaria parasite plasmepsins: More than just plain old degradative pepsins.

Authors:  Armiyaw S Nasamu; Alexander J Polino; Eva S Istvan; Daniel E Goldberg
Journal:  J Biol Chem       Date:  2020-05-04       Impact factor: 5.157

3.  Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine.

Authors:  Ritu Banerjee; Jun Liu; Wandy Beatty; Lorraine Pelosof; Michael Klemba; Daniel E Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-08       Impact factor: 11.205

Review 4.  Proteases as regulators of pathogenesis: examples from the Apicomplexa.

Authors:  Hao Li; Matthew A Child; Matthew Bogyo
Journal:  Biochim Biophys Acta       Date:  2011-06-13

5.  New class of small nonpeptidyl compounds blocks Plasmodium falciparum development in vitro by inhibiting plasmepsins.

Authors:  S Jiang; S T Prigge; L Wei; T H Hudson; L Gerena; J B Dame; D E Kyle
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

Review 6.  Structural studies of vacuolar plasmepsins.

Authors:  Prasenjit Bhaumik; Alla Gustchina; Alexander Wlodawer
Journal:  Biochim Biophys Acta       Date:  2011-04-20

7.  Crystal structures of the free and inhibited forms of plasmepsin I (PMI) from Plasmodium falciparum.

Authors:  Prasenjit Bhaumik; Yasumi Horimoto; Huogen Xiao; Takuya Miura; Koushi Hidaka; Yoshiaki Kiso; Alexander Wlodawer; Rickey Y Yada; Alla Gustchina
Journal:  J Struct Biol       Date:  2011-04-20       Impact factor: 2.867

8.  Recombinant plasmepsin 1 from the human malaria parasite plasmodium falciparum: enzymatic characterization, active site inhibitor design, and structural analysis.

Authors:  Peng Liu; Melissa R Marzahn; Arthur H Robbins; Hugo Gutiérrez-de-Terán; David Rodríguez; Scott H McClung; Stanley M Stevens; Charles A Yowell; John B Dame; Robert McKenna; Ben M Dunn
Journal:  Biochemistry       Date:  2009-05-19       Impact factor: 3.162

9.  Inhibition of malaria parasite development by a cyclic peptide that targets the vital parasite protein SERA5.

Authors:  W Douglas Fairlie; Tim P Spurck; Joanne E McCoubrie; Paul R Gilson; Susanne K Miller; Geoffrey I McFadden; Robyn Malby; Brendan S Crabb; Anthony N Hodder
Journal:  Infect Immun       Date:  2008-06-30       Impact factor: 3.441

10.  Computational perspectives into plasmepsins structure-function relationship: implications to inhibitors design.

Authors:  Alejandro Gil L; Pedro A Valiente; Pedro G Pascutti; Tirso Pons
Journal:  J Trop Med       Date:  2011-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.